Pular para o conteúdo
Síndrome de polineuropatia-perturbação do desenvolvimento intelectual-acromicria-menopausa precoce
ORPHA:2928CID-10 · Q87.8DOENÇA RARA
Sistema ósseoInício adulta
Sinônimos clínicos: Síndrome Lundberg

A síndrome de polineuropatia, deficiência intelectual, mãos e pés pequenos e menopausa precoce é uma síndrome genética rara que causa deficiência intelectual. Ela se caracteriza por: deficiência intelectual, uma doença que afeta vários nervos (polineuropatia), baixa estatura, membros curtos, dedos das mãos e pés curtos (braquidactilia) e falha prematura dos ovários, resultando em menopausa precoce. Apenas um caso familiar, envolvendo três mulheres, foi descrito, e não há outros relatos na literatura médica desde 1971.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A síndrome de polineuropatia, deficiência intelectual, mãos e pés pequenos e menopausa precoce é uma condição genética extremamente rara que compromete o desenvolvimento cognitivo e o funcionamento dos nervos do corpo. A família costuma notar baixa estatura, dedos das mãos e pés mais curtos, além de fraqueza nos músculos, dificuldades para caminhar e interrupção precoce das menstruações. Não existe um medicamento curativo dispensado na rede pública nem diretrizes em PCDT oficial do Ministério da Saúde para esta síndrome. O suporte no SUS é realizado por meio de acompanhamento clínico geral e procedimentos de atendimento em reabilitação para doenças raras.

📋
Informacoes curadas por IA — podem conter imprecisoes

A síndrome de polineuropatia, deficiência intelectual, mãos e pés pequenos e menopausa precoce é uma síndrome genética rara que causa deficiência intelectual. Ela se caracteriza por: deficiência intelectual, uma doença que afeta vários nervos (polineuropatia), baixa estatura, membros curtos, dedos das mãos e pés curtos (braquidactilia) e falha prematura dos ovários, resultando em menopausa precoce. Apenas um caso familiar, envolvendo três mulheres, foi descrito, e não há outros relatos na literatura médica desde 1971.

Medicamentos
11 com registro
NATIFA, SANDRENA, ESTRADIOL+ACETATO DE NORETISTERONA

Tem tratamento?

✓ 11 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
NATIFASANDRENAESTRADIOL+ACETATO DE NORETISTERONASYSTEN SEQUISUPREMANATIFA PROSYSTENESTALIS

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
3
pacientes catalogados
Início
Adult
🏥
SUS: Cobertura parcialScore: 35%
5 procedimentos SIGTAPCID-10: Q87.8
🇧🇷Dados SUS / DATASUS
EXAMES E PROCEDIMENTOS RELACIONADOS (5)
•
Cariótipo — bandas G, Q ou R
•
Pesquisa de microdeleções/microduplicações por FISH
•
Sequenciamento completo do exoma (WES)
•
Dosagem de alfa-fetoproteína
•
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
5 sintomas
💪
Músculos
1 sintomas
🧠
Neurológico
1 sintomas
📏
Crescimento
1 sintomas
❤️
Coração
1 sintomas

+ 6 sintomas em outras categorias

Características mais comuns

90%prev.
Reflexos tendíneos reduzidos
Muito frequente (99-80%)
90%prev.
Braquidactilia
Muito frequente (99-80%)
90%prev.
Micromelia
Muito frequente (99-80%)
90%prev.
Fraqueza muscular
Muito frequente (99-80%)
90%prev.
Velocidade de condução nervosa diminuída
Muito frequente (99-80%)
90%prev.
Deficiência intelectual
Muito frequente (99-80%)
15sintomas
Muito frequente (9)
Frequente (3)
Ocasional (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 15 características clínicas mais associadas, ordenadas por frequência.

Reflexos tendíneos reduzidosReduced tendon reflexes
Muito frequente (99-80%)90%
BraquidactiliaBrachydactyly
Muito frequente (99-80%)90%
Muito frequente (99-80%)90%
Fraqueza muscularMuscle weakness
Muito frequente (99-80%)90%
Velocidade de condução nervosa diminuídaDecreased nerve conduction velocity
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico2026122 papers
Linha do tempo
2026Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de polineuropatia-perturbação do desenvolvimento intelectual-acromicria-menopausa precoce

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de polineuropatia-perturbação do desenvolvimento intelectual-acromicria-menopausa precoce

Centros para Síndrome de polineuropatia-perturbação do desenvolvimento intelectual-acromicria-menopausa precoce

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Design and in vitro/in vivo evaluation of a compound estradiol-progesterone patch for the treatment of menopausal syndrome.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2026 Mar 17

Transdermal estradiol patches have been widely used for the prevention and treatment of ovarian insufficiency. However, they should not be used alone and must be combined with adequate progestin therapy for a full course to provide sufficient endometrial protection. This study aimed to develop a compound estradiol-progesterone transdermal patch by incorporating progesterone into the estradiol patch to reduce the number of medications administered, and to evaluate its feasibility and efficacy. Key excipients in the patch, including pressure-sensitive adhesive, permeation enhancers, and plasticizers, were screened and optimized. The optimal patch formulation was selected based on evaluation criteria including adhesion, cumulative release rate, cumulative permeation, and appearance. Subsequently, a menopausal rat model was established to conduct single-dose pharmacokinetic studies and multiple-dose pharmacodynamic evaluations, comparing results with a commercial estradiol patch and progesterone injection. Results demonstrated that the prepared patches exhibited good conformability and adhesion. The cumulative release rate of E2 over 72 hours was 94.58%, with a cumulative permeation rate of 154.56 μg·cm-2 over 24 hours. These results are comparable to those of commercially available estradiol patches, which exhibit a 72-hour cumulative release rate of 90.02% and a 24-hour cumulative permeation rate of 148.69 μg·cm-2. P4 exhibited a 72-hour cumulative release rate of 92.45% and a 24-hour cumulative permeation rate of 104.92 μg·cm-2, achieving the clinically effective dose threshold. The time to peak concentration and residence time for a single application were longer than those of ESTRANA® Tapes and progesterone injection. Compared with the model group, the combined administration group showed a significantly increased uterine coefficient without the abnormal endometrial thickening observed after using estradiol patches alone. This patch achieves synchronized delivery of estrogen and progesterone, meeting the clinical demand for long-acting hormone therapy.

#2

Efficacy and security of traditional Chinese medicine in the treatment of perimenopausal insomnia in the Chinese population: a systematic review and meta-analysis of randomized controlled trials.

Frontiers in neurology2026

Traditional Chinese medicine (TCM) has been widely applied in the management of perimenopausal insomnia (PMI), yet comprehensive evidence on its efficacy and safety remains insufficient. We aimed to systematically evaluate the therapeutic effects and safety of TCM interventions in PMI treatment. Randomized controlled trials (RCTs) that compared TCM interventions with Western medicine for patients with PMI were searched across eight databases from inception to August 1, 2025. Methodological quality, risk of bias, and certainty of evidence were assessed using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines and Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Meta-analysis was performed using RevMan 5.4 and R 4.4.2 software. A total of 48 RCTs involving 5,037 patients were included. Meta-analysis showed that TCM was superior to Western medicine in overall efficacy (RR = 1.20, 95% CI [1.17, 1.23]) and had fewer adverse reactions (RR = 0.30, 95% CI [0.24, 0.38]). Besides, TCM interventions significantly improved Pittsburgh Sleep Quality Index (PSQI) score (MD = -2.57, 95% CI [-3.01, -2.14]), reduced luteinizing hormone (LH) (MD = -4.51, 95% CI [-6.15, -2.87]) and follicle-stimulating hormone (FSH) (MD = -8.67, 95% CI [-10.96, -6.38]), increased estradiol (E2) level (MD = 9.64, 95% CI [7.45, 11.82]), and decreased Kupperman Menopausal Index (KMI) score (MD = -6.01, 95% CI [-8.56, -3.47]), Traditional Chinese Medicine Syndrome (TCMS) score (SMD = -2.27, 95% CI [-3.49, -1.05]), Self-Rating Anxiety Scale (SAS) score (MD = -4.77, 95% CI [-5.77, -3.76]), and Self-Rating Depression Scale (SDS) score (MD = -2.96, 95% CI [-5.80, -0.12]). TCM interventions demonstrate notable efficacy and safety in managing PMI by improving sleep quality, hormonal balance, and mental health. However, methodological limitations and heterogeneity warrant further validation through large-scale, multicenter, rigorously designed RCTs. PROSPERO registration number CRD420251127129.

#3

Impact of fractional CO2 laser therapy on vaginal wall histology in breast cancer survivors.

Lasers in medical science2026 Feb 10

To investigate histological changes in the vaginal wall of breast cancer survivors (BCSs) with genitourinary syndrome of menopause (GSM) treated with five sessions of fractional CO₂ vaginal laser therapy, focusing on epithelial morphology and stromal extracellular matrix composition. In this prospective single-center study, 26 BCSs underwent five sessions of fractional CO2 vaginal laser therapy. Vaginal punch biopsies were collected at baseline and four to six weeks after completing the final session. Mucosal morphology was classified (Type 1, 2, or 3) independently by two pathologists, blinded to baseline and follow-up status. Stromal elastin, total collagen, and collagen types I and III were quantified by digital image analysis of Verhoeff-Van Gieson, Masson's trichrome, and immunohistochemistry. Paired tests and the Stuart-Maxwell test evaluated changes over time. At baseline, 42.3% of participants were classified as Type 1, 19.2% as Type 2, and 38.5% as Type 3 mucosal morphology. Elastin index increased from 33.1% to 56.8% (p < 0.01), and collagen type III index from 44.5% to 58.4% (p = 0.03), while total collagen and collagen type I showed no significant change. No significant differences in epithelial microscopic features were observed (Stuart-Maxwell p = 0.16). Fractional vaginal CO₂ laser therapy was associated with selective stromal remodelling in BCSs - higher elastin and collagen type III indices, but without detectable improvement in epithelial morphology. Given the absence of a control group, the short follow-up, and limited epithelial morphometry due to section orientation, these findings should be interpreted as preliminary histological evidence of a stromal response rather than a confirmation of functional or regenerative benefit. Registry: ClinicalTrials.gov, TRN: (NCT06007027). Registration date: 1 August 2023.

#4

Effect of Bioptron light therapy on dryness of eyes in postmenopausal women: a randomized controlled trial.

Lasers in medical science2026 Feb 04

To examine the short-term therapeutic effects of Bioptron light therapy (BLT) on dry eye disease (DED) in postmenopausal women. Sixty postmenopausal women diagnosed with DED, aged 50-62 years with a body mass index ≤ 30 kg/m², were randomly assigned to two equal groups. The Bioptron group (n = 30) received BLT for 10 min, twice weekly, along with an educational program for four weeks. The control group (n = 30) received the same educational program only. Outcomes were measured using Schirmer's test (Schirmer I) for basal tear secretion, Tear Break-Up Time (TBUT) for tear film stability, and the Dry Eye-related Quality of Life Score (DEQS) for quality of life (QOL). Both groups exhibited significant improvements post-treatment compared to pre-treatment in all variables, with greater percentage changes from baseline in the BLT group. Between-group comparisons revealed significantly higher improvements in the BLT group: Schirmer's test (Schirmer I) improved by MD = 8.7 (95% CI: 7.64-9.76; p = 0.001), TBUT by MD = 2.97 (95% CI: 1.7-4.3; p = 0.007), and DEQS decreased by MD = - 24.1 (95% CI: -37 to - 17.1; p = 0.002). Compared with standardized education alone, adjunctive Bioptron light therapy significantly enhanced tear secretion, tear film stability, and patient-reported symptoms, suggesting its potential as an effective non-pharmacological option for managing dry eye in postmenopausal women. The trial was registered at Clinical Trials.gov (Identifier: NCT05964673).

#5

Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.

Circulation2026 Feb 17

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk than other groups, we have begun to appreciate the potential risk for ACS in this younger subset of women. Whereas atherosclerotic disease (obstructive or nonobstructive) accounts for most presentations, a substantial number are attributable to nonatherosclerotic causes, including spontaneous coronary artery dissection, epicardial coronary artery spasm, and coronary embolism. A major challenge at present is the lack of specific data and evidence for the diagnosis and management of these women. Unfortunately, as a result of several factors, diagnostic delays, misclassification, and mistreatment appear to be more frequent than for other patient groups. Of great concern, younger women less often receive guideline-directed therapies after ACS, and younger women with ACS have been shown to have worse outcomes than young men with ACS. Management should be tailored to the unique pathophysiology in premenopausal women, emphasizing early diagnosis, a low threshold for invasive angiography if appropriate, and special consideration in the pregnant patient. Secondary prevention must address traditional cardiovascular and disease-specific risk factors, with consideration of current or future pregnancies and lactation. Participation in cardiac rehabilitation is associated with improved outcomes and must be strongly encouraged, whereas attention to potential post-ACS depression and anxiety is an important aspect of holistic care. Increased patient and health care professional awareness and improved representation in research are critical to closing the knowledge and outcome gaps in premenopausal women with ACS.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

[Preventing dementia in an ageing society].

Therapeutische Umschau. Revue therapeutique
2026

Proteolytic Imbalance of the MMP/E-Cadherin Axis in Genitourinary Syndrome of Menopause: A Cross-Sectional Study.

International journal of women's health
2026

Lifestyle and Complementary Approaches to Polycystic Ovary Syndrome During Perimenopause and Menopause A Scoping Review.

American journal of lifestyle medicine
2026

Safety of vaginal estrogen in breast cancer survivors: Current evidence on systemic absorption and oncologic outcomes.

Maturitas
2026

Fractional CO2 laser therapy for genitourinary syndrome of menopause: symptom-specific trajectories, exposure-outcome associations, and ultrasonographic changes in vulvar soft tissue in a cohort of 826 women.

Frontiers in reproductive health
2026

Design and in vitro/in vivo evaluation of a compound estradiol-progesterone patch for the treatment of menopausal syndrome.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2026

Global trends in psychosexual and emotional health challenges among breast cancer survivors (1999-2024): Implications for public health and survivorship care.

Public health in practice (Oxford, England)
2026

Polycystic ovary syndrome and risk of endometrial hyperplasia and endometrial cancer in women with abnormal uterine bleeding: A systematic review and meta-analysis.

Biomolecules &amp; biomedicine
2026

Anxiolytic, anti-depressive and cognition-enhancing effects of total saponins from lily bulbs in ovariectomized mice: A potential therapy for menopause-associated emotional disorders.

Journal of integrative medicine
2026

Short-term outcomes and tolerability of a hyaluronic acid-based vaginal gel in the management of genitourinary syndrome of menopause: a retrospective observational study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
2026

Potential Harm of the Use of the Word "Benign" in Gynecologic Care.

Journal of obstetric, gynecologic, and neonatal nursing : JOGNN
2026

Diode Laser and Radiofrequency for Genitourinary Syndrome of Menopause: A Comparative Analysis.

Healthcare (Basel, Switzerland)
2026

Intra-Individual Variability of Lipoprotein(a) After Acute Coronary Syndrome: A Long-Term Cohort Study.

Journal of clinical medicine
2026

Radiofrequency versus vaginal estrogen for menopausal sexual dysfunction: a systematic review and meta-analysis of randomized clinical trials.

Sexual medicine reviews
2026

The Role of the Vaginal Microbiome in Gynecological Diseases: Mechanistic Insights and Emerging Interventions.

Biology
2026

Innovative mitochondria-based holistic 3PM approach to female health status: Facts and outlook.

The EPMA journal
2026

Circulating vitamin D and follicle-stimulating hormone levels are associated with subclinical atherosclerosis in climacteric women with menopausal syndrome.

Frontiers in endocrinology
2026

The tight bond between Fanconi anemia and aging.

Frontiers in aging
2026

Vaginal pixel CO2 laser versus topical use of promestriene for genitourinary syndrome of menopause.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
2026

Obesity and female reproductive health in Asian population.

Obesity pillars
2026

Hidden Cardiovascular Risk: Early Menopause Triggering Acute Coronary Syndrome (ACS) in Young Patients.

Cureus
2026

[Effects and mechanisms of Renshen Guben Oral Liquid combined with Jingfang Granules on ovarian aging in perimenopausal mice].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
2026

Comparison of menopausal symptoms in women with and without type 2 diabetes mellitus: a cross-sectional study.

Climacteric : the journal of the International Menopause Society
2026

Reproductive potential in mosaic Turner syndrome: impact of karyotype pattern and mosaicism ratio.

Climacteric : the journal of the International Menopause Society
2026

Development and bioavailability testing of an estetrol and estetrol-zinc-containing vaginal hydrogel: a novel hydroxyethyl cellulose and hydroxypropyl-β-cyclodextrin-based formulation.

Menopause (New York, N.Y.)
2026

Erbium:YAG Laser Combined With Plant-Derived Exosomes (ASCEplus IRLV) for Genital Rejuvenation.

Aesthetic surgery journal
2026

Efficacy and security of traditional Chinese medicine in the treatment of perimenopausal insomnia in the Chinese population: a systematic review and meta-analysis of randomized controlled trials.

Frontiers in neurology
2026

From bench to bedside: unlocking the anti-inflammatory, antioxidant, and anticancer promise of curcumin in gynecology.

Frontiers in medicine
2025

Dry Eye in Post-menopausal Women Visiting Community Eye Centre: An Observational Study.

JNMA; journal of the Nepal Medical Association
2026

Sex hormones and arrhythmia risk in women with long QT syndrome.

Heart rhythm
2026

The association between smoking and joint pain in women attending a specialized menopause clinic.

Climacteric : the journal of the International Menopause Society
2026

Treating Genitourinary Syndrome of Menopause in Postmenopausal Women with a History of Breast Cancer.

Drugs &amp; aging
2026

Postural Orthostatic Tachycardia Syndrome, Menopause and Hormone Replacement Therapy: Clinical Decisions in Times of Uncertainty.

Journal of clinical medicine
2026

Vulvovaginal Collagen Injection as a Regenerative Strategy in Genitourinary Syndrome of Menopause: Results of a Pilot Study.

Journal of clinical medicine
2026

A mixed-method analysis of health literacy and indicators of well-being in women with polycystic ovary syndrome across the lifespan.

Therapeutic advances in reproductive health
2026

Effect of Hormone Replacement Therapy on Liver and Cardiometabolic Outcomes in Peri-Menopausal MASLD.

Liver international : official journal of the International Association for the Study of the Liver
2026

Yinhuo Decoction attenuates depression-like behaviors and promotes M2 microglia polarization by regulating PI3K/Akt/NF-κB signaling pathway in a murine model of menopausal depression.

Journal of ethnopharmacology
2026

Female Underweight/Undernutrition Syndrome (FUS): An Emerging Health Concept in Premenopausal Women - Secondary Publication (English Translation of the Japanese Statement).

The journal of obstetrics and gynaecology research
2026

Association between reproductive span and postmenopausal metabolic syndrome: a cross-sectional study in China.

Menopause (New York, N.Y.)
2026

Postoperative Management After Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer Syndrome: A Narrative Review on Balancing Oncologic Benefit and Quality of Life.

Cureus
2026

[Menopausal hormone therapy in patients with cardiovascular and metabolic diseases: an interdisciplinary Delphi consensus among Russian gynecologists, cardiologists, endocrinologists, gerontologists and geriatricians, phlebologists, and clinical pharmacologists].

Terapevticheskii arkhiv
2026

Skin deep: dermatologic challenges in PCOS through the female lifespan.

Expert review of endocrinology &amp; metabolism
2026

Altered microbial colonization of the urogenital tract in female overactive bladder syndrome.

American journal of obstetrics and gynecology
2026

[A pilot study on health issues, literacy, and presenteeism related to male menopause among working Japanese men].

Sangyo eiseigaku zasshi = Journal of occupational health
2026

Effectiveness of radiofrequency therapy combined with pelvic floor muscle training in breast cancer survivors with genitourinary syndrome of menopause: a study protocol.

European journal of obstetrics, gynecology, and reproductive biology
2026

Topical hyaluronic acid and oxygen for urinary incontinence: a double-center retrospective study.

Frontiers in medicine
2026

Gut microbiota and metabolic syndrome in postmenopausal women: a narrative review of mechanisms and dietary recommendations.

Minerva endocrinology
2026

Menopausal hormone therapy and breast cancer: risk and management.

Current opinion in obstetrics &amp; gynecology
2026

How postmenopausal osteoporosis influences epidemiology and clinical features of CRPS-1.

Journal of bone and mineral metabolism
2026

Impact of fractional CO2 laser therapy on vaginal wall histology in breast cancer survivors.

Lasers in medical science
2026

Efficacy of nonablative radiofrequency on sexual function in postmenopausal women: a randomized clinical trial.

Menopause (New York, N.Y.)
2026

Risk of Cancer With Hormone Replacement Therapy: A Narrative Review.

BJOG : an international journal of obstetrics and gynaecology
2026

Reproductive factors, insulin resistance surrogate indices, and circadian syndrome among middle-aged and elderly women a mediation analysis using two-national cohorts.

Diabetes research and clinical practice
2026

Sex and menopause-based differences in presentation of early Lyme disease: A prospective cohort study.

Clinical and experimental medicine
2026

Post-licensure safety surveillance of 9-valent human papillomavirus vaccine using the vaccine adverse event reporting system, 2014-2024.

Frontiers in public health
2026

The new toolbox for reducing painful sex in menopause.

Current opinion in obstetrics &amp; gynecology
2026

Safety and Impacts of Physical Activity for Individuals Living With Hypermobility Spectrum Disorders and Hypermobile Ehlers-Danlos Syndrome: Protocol for a Scoping Review.

JMIR research protocols
2026

Effect of Bioptron light therapy on dryness of eyes in postmenopausal women: a randomized controlled trial.

Lasers in medical science
2026

Neurologic Complications of Pregnancy and Menopause.

Continuum (Minneapolis, Minn.)
2026

Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.

Circulation
2025

Comparative effectiveness of different acupuncture therapies for perimenopausal syndrome: a systematic review and network meta-analysis.

Frontiers in neurology
2026

Vaginal vitamin D for Genitourinary syndrome of menopause: a cohort study and literature review.

Future science OA
2026

A review of estrogens used in menopausal hormone therapy.

Current opinion in obstetrics &amp; gynecology
2026

Understanding patient priorities: Sexual health and hereditary ovarian cancer syndromes.

Gynecologic oncology
2026

Aesthetically relevant symptoms of menopause transition: Impact and approach to management.

Clinics in dermatology
2026

The effect of estradiol and selective estrogen receptor modulators on lipid profile in the ovariectomized rat model.

Research in pharmaceutical sciences
2026

Effects of 12-week aquatic HIIT on blood pressure lipid profile and BaPWV in postmenopausal women with different ACE genotypes.

Scientific reports
2025

Case Report: Postmenopausal hyperandrogenism misled by adrenal incidentaloma: a rare case of androgen-secreting ovarian adult granulosa cell tumor and clinical implications.

Frontiers in oncology
2026

Late Cervical Recurrence of Invasive Lobular Carcinoma Ten Years After Primary Breast Cancer: A Case Report and Review of the Literature.

Healthcare (Basel, Switzerland)
2026

The Relationship Between Bone Health Status of Post-Menopausal Women with Non-Functional Adrenal Tumours/Mild Autonomous Cortisol Secretion and Their Baseline Morning Adrenocorticotropic Level.

Diagnostics (Basel, Switzerland)
2026

Intravaginal dehydroepiandrosterone for the treatment of vulvovaginal atrophy: a systematic review and meta-analysis.

Menopause (New York, N.Y.)
2026

Decision-making surrounding ovarian cancer risk-reducing surgery: perspectives from a diverse population.

Menopause (New York, N.Y.)
2026

Effects of ovariectomy of rat on tongue neuropathy: Relevance to burning mouth syndrome.

Journal of dental sciences
2026

[Optical Coherent Tomography: A Tool for Non-Invasive Biopsy in Women's Health].

Harefuah
2026

Associations between Premature Menopause and Cardiovascular-Kidney-Metabolic Syndrome: A Prospective Cohort Study from the UK Biobank.

Biomedical and environmental sciences : BES
2026

Hormone Replacement Therapy and Cardiovascular Outcomes by Race and Ethnicity: MESA (Multi-Ethnic Study of Atherosclerosis).

JACC. Advances
2026

Triglyceride-glucose index and cardiovascular disease by cardiovascular-kidney-metabolic syndrome and socioeconomic status among postmenopausal women.

Atherosclerosis
2026

[Clinical and histological evaluation of fractional CO2 laser treatment for genitourinary syndrome of menopause].

Gynecologie, obstetrique, fertilite &amp; senologie
2026

Hereditary Risk Assessment of Cancer Using Clinical History in Patients Diagnosed with Breast or Ovarian Cancer Receiving Treatment at Tertiary Care Hospital in Western Rajasthan - A Cross-sectional Study.

Annals of African medicine
2026

From menarche to menopause: estrogenic influences on stroke-related depression in women.

Frontiers in neuroendocrinology
2026

The uptake rate of risk-reducing salpingo-oophorectomy among Thai women with breast cancer and germline BRCA pathogenic or likely pathogenic variants.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
2026

Evaluation of symptom improvement over time after fractional CO2 laser therapy in women with genito-urinary syndrome.

Journal of gynecology obstetrics and human reproduction
2026

Quantitative Systems Toxicology Modeling with DILIsym to Support Phase 3 Dose Selection for Fezolinetant.

Clinical pharmacology and therapeutics
2025

Atypical Polypoid Adenomyoma in a Patient with Hyperprolactinemia: a Novel Case and Systematic Review of the Systematic Reviews.

Maedica
2026

Beyond malignancy: Unravelling the Enigma of Meigs syndrome in ovarian fibroma.

Tropical doctor
2026

Ingenol-Mediated SIRT1-LXRα Signaling Reduces Lipid Accumulation and Alleviates Postmenopausal Liver Damage.

Phytotherapy research : PTR
2026

Sex Differences in Atherosclerosis and its Clinical Complications.

Current atherosclerosis reports
2025

Translational Lifestyle Medicine Approaches to Cardiovascular-Kidney-Metabolic Syndrome.

Healthcare (Basel, Switzerland)
2026

Metabolic Health Differences Among Women of Age-Based Pre-, Peri-, and Post-Menopausal Stages.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2025

[Randomized, double-blind, double-simulated, parallel controlled clinical trial of Dingkundan Oral Liquid in treating primary dysmenorrhea with cold coagulation and blood stasis].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
2026

Effects of a combined training program on lipid metabolism metabolic syndrome and physical fitness in perimenopausal Chinese female teachers.

Scientific reports
2026

Menopausal transition and metabolic syndrome risk: insights from the Chinese PALM longitudinal cohort.

Climacteric : the journal of the International Menopause Society
2026

Urobiome Analysis in Interstitial Cystitis/Bladder Pain Syndrome Reveals Nuanced Differences Associated with Localized Pain.

bioRxiv : the preprint server for biology
2025

Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis.

The Canadian journal of urology
2025

[Menopause, hormone therapy and cardiovascular risk].

Medecine sciences : M/S
2026

The broader implications of menstrual health in eating disorders: Matters Arising from Porter (2025).

Journal of eating disorders
2025

Distinguishing Polycystic Ovary Syndrome Phenotype D from Functional Hypothalamic Amenorrhea with Polycystic Ovarian Morphology: Clinical and Hormonal Insights from a Pilot Retrospective Study.

Journal of menopausal medicine
2025

Bioactive Compounds in Natural Remedies and Functional Foods for Managing Recurrent Urinary Tract Infections in Postmenopausal Women.

Journal of menopausal medicine
2025

Bibliometric analysis of scientific publications on the effects of rangeland and wild plants on women's health.

African journal of reproductive health
2025

Anti-aging effects of the adrenal androgens dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanisms of action and beneficial effects in older people.

Endocrine journal
2026

Insulin levels early in perimenopause inform vasomotor symptom incidence across the menopausal transition.

The Journal of clinical endocrinology and metabolism
2026

Sex differences in low arousal threshold in obstructive sleep apnea.

Respiratory medicine
2025

Hormones, heat, and health: a comprehensive review of sex-based differences in brown and beige fat biology.

Biology of sex differences
2026

Postmenopausal labial adhesion: A 5-stage classification system and clinical outcomes in a 14-patient series.

Maturitas
2025

Topical Spermidine Hyaluronate (Spd-HA) in Vulvovaginal Atrophy: A Preliminary Study.

Medicina (Kaunas, Lithuania)
2025

Feasibility of Multimodal Energy-Based Therapy for Pelvic Floor Disorders.

Medicina (Kaunas, Lithuania)
2026

Integrating obesity management into menopause care recommendations comments on the 2025 European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause.

European journal of endocrinology
2025

Prevalence of hysterectomy in urban China and associations between metabolic disorders and hysterectomy: a multicenter population-based study involving over 9 million women.

BMC medicine
2025

The Effects of Health Literacy, Social Support, and Health-Promoting Behaviors on Metabolic Syndrome Among Middle-Aged and Older Women Living in Rural Areas of Republic of Korea.

Healthcare (Basel, Switzerland)
2025

Clinical, Biochemical, and Psychological Predictors of Metabolic Syndrome in Climacteric Women.

Healthcare (Basel, Switzerland)
2026

Metabolic obesity phenotypes and breast cancer risk before and after menopause: A nationwide cohort study in South Korea.

Cancer
2025

The human ovarian reserve: the narrative and the science.

Human reproduction update
2026

Non-hormonal vaginal gel improves vaginal and sexual health in menopausal women: results from a 6-month prospective study.

European journal of obstetrics, gynecology, and reproductive biology
2026

Associations between depressive trajectories and progression to type 2 diabetes mellitus in postmenopausal women with prediabetes: Findings from a national ten-year follow-up study.

Journal of affective disorders
2025

Sex-Specific Impact of Metabolic Syndrome on Brain Structures Vulnerable to Alzheimer's Disease: A Cross-Sectional Study in a Brazilian Cohort.

Brain sciences
2025

International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopause.

Climacteric : the journal of the International Menopause Society
2026

Management of Genitourinary Syndrome of Menopause in Korean Breast Cancer Survivors by Fractional CO₂ Laser Treatment.

Yonsei medical journal
2025

Duhuo Jisheng Decoction mitigates postmenopausal rheumatoid arthritis by suppressing eEF2K-mediated cellular senescence.

Pharmacological research
2025

Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer.

Journal of minimally invasive gynecology
2025

Randomized clinical trial of vaginal microbiota in menopausal genitourinary syndrome using radiofrequency and topical estriol.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
2026

Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
2025

Risk Factors Associated With the Number of Symptoms and Distress Caused by Genitourinary Syndrome of Menopause in Taiwanese Women.

The Kaohsiung journal of medical sciences
2026

Underdiagnosed and overmedicated: Investigating the management of urinary tract infection and vaginal estrogen use in a large cohort of postmenopausal women.

Maturitas
2025

Safety and performance of photobiomodulation delivered by vaginal probe in patients with genitourinary syndrome of menopause.

Climacteric : the journal of the International Menopause Society
2025

Prevalence of metabolic syndrome among Iranian postmenopausal females: A systematic review and meta-analysis.

PloS one
2025

Vaginal Estrogen Utilization Among Medicare Beneficiaries With Genitourinary Syndrome of Menopause.

JAMA network open
2026

Limosilactobacillus reuteri NCU-37 alleviates leuprorelin-induced perimenopausal syndrome in infertile women by modulating the gut microbiota: a randomized controlled trial.

Food &amp; function
2026

Weight Management Through a Woman's Life Stages: A Practical Evidence-Based Guide.

Journal of women's health (2002)
2025

Longitudinal study of plasma metabolites during menopause and their associations with later onset of metabolic syndrome.

The Journal of clinical endocrinology and metabolism
2025

FDA Boxed Warning Removal on Menopause Hormone Therapy: What Geriatricians Should Know.

Journal of the American Geriatrics Society
2025

Chai-shen powder treated perimenopausal syndrome through the PI3K-Akt/cAMP signaling pathway: integrated clinical analysis, network pharmacology, microRNA and animal experiment.

Climacteric : the journal of the International Menopause Society
2025

When Should We Biopsy? A Risk Factor-Based Predictive Model for EIN and Endometrial Cancer.

Cancers
2025

Association between BMI trajectories and metabolic syndrome in postmenopausal women: a cross-sectional study from NHANES 1999-2018.

BMC public health
2026

Transitions in metabolic syndrome clustering patterns before and after menopause: a latent transition analysis in Korean women.

Menopause (New York, N.Y.)
2026

The effect of inflammation on sexual desire and sexual function in pre- and post-menopausal women is moderated by sexual violence history.

The journal of sexual medicine
2025

The Vaginal Microbiome and Recurrent and Chronic Urinary Tract Infection.

International urogynecology journal
2025

Narrative Review of Clinical Indices and Imaging Tools, With a Proposal for an Integrative Grading Scale for Vulvovaginal Aging.

Cureus
2026

Novel PNPLA6 Variants: Hypogonadotropic Hypogonadism, Pituitary Hypoplasia, Anosmia, and Cerebellar Atrophy in Siblings.

JCEM case reports
2025

Impact of vaginal estradiol on the genitourinary syndrome of menopause, vaginal microbiome and mucosal immune mediators in women living with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2025

The effect of hormone replacement therapy on musculoskeletal pain in menopausal women: A systematic review and meta-analysis.

Post reproductive health
2025

PREVALENCE OF 25-HYDROXYCHOLECALCIFEROL DEFICIENCY AND METABOLIC SYNDROME IN CROATIAN WOMEN WITH NEWLY DIAGNOSED BREAST CANCER.

Acta clinica Croatica
2025

Synthesizing the latest guideline-based recommendations for the management of female hypogonadism.

Archives of endocrinology and metabolism
2025

Are Hormones a risk or an opportunity? Strategies for managing women predisposed to gynecological cancers.

Maturitas
2025

The effect of age on the clinical presentation and treatment of women with psychosis: secondary analysis of the IMPaCT Randomised Clinical Trial.

BJPsych open
2026

Sea urchin bioactive compounds: emerging interventions for age-related diseases.

Ageing research reviews
2025

Precision pharmacology in menopause: advances, challenges, and future innovations for personalized management.

Frontiers in reproductive health
2025

Development and validation of an integrated preclinical model mimicking cardiometabolic risk in postmenopausal female rats.

Scientific reports
2025

Genitourinary syndrome of menopause induced by breast cancer treatments: a randomised clinical trial protocol comparing multimodal pelvic floor physiotherapy and fractional CO2 laser therapy (PILME study).

BMJ open
2025

Genitourinary syndrome of menopause.

The British journal of general practice : the journal of the Royal College of General Practitioners
2025

Menopausal Hormone Therapy-Risks, Benefits and Emerging Options: A Narrative Review.

International journal of molecular sciences
2025

Menopause as a critical window for cardiovascular-kidney-metabolic syndrome prevention: a call for integrated women's health approaches.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
2025

Is There Evidence of Diagnostic and Treatment Gaps for LUTS in Post-Menopausal Women With Genitourinary Syndrome of the Menopause? ICI-RS 2025.

Neurourology and urodynamics
2026

A pilot study of vaginal nerve fiber and blood vessel density in postmenopausal women with genitourinary syndrome of menopause.

Menopause (New York, N.Y.)
2026

Musculoskeletal disorders following hysterectomy with ovarian conservation: a population-based cohort study.

Menopause (New York, N.Y.)
2025

Citri Reticulatae Pericarpium improves obesity in OVX mice by regulating the gut microbiota and suppressing appetite.

Food &amp; function
2025

Exploring the association between polycystic ovary syndrome and female sexual dysfunction: a cross-sectional study.

Reproductive biology and endocrinology : RB&amp;E
2025

From physiology to psychology: An integrative review of menopausal syndrome.

World journal of psychiatry
2025

Vaginal epithelial estrogen receptor α coordinates glycogen deposition, microbial stability, and pH regulation in mice.

bioRxiv : the preprint server for biology
2026

Coenzyme Q10 ameliorates obesity by promoting white adipose tissue browning and preserving mitochondrial dynamics in ovariectomized rats fed a high-fat diet.

The Journal of nutritional biochemistry
2026

Regenerative Effect of Vaginal Injections of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Ovariectomized Rats.

Aesthetic plastic surgery
2026

Adaptation of the Genitourinary Syndrome of Menopause Symptoms and Vaginal Treatments Acceptability Questionnaire Into Turkish.

International urogynecology journal
2025

Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
2025

The evolution of the global disease burden of polycystic ovary syndrome and the role of regional heterogeneity in high body mass index exposure: a spatiotemporal analysis based on the global burden of disease 2021.

Frontiers in reproductive health
2025

[Case of head-facial herpes zoster in perimenopausal women using Zheng's cold reducing acupuncture as primary treatment].

Zhongguo zhen jiu = Chinese acupuncture &amp; moxibustion
2026

Impact of a yoga intervention over 6, 12, and 24 months in sedentary climacteric women with metabolic syndrome.

Complementary therapies in medicine
2025

Gynecologic Cancers: Endometrial Cancer.

FP essentials
2026

Association between relative handgrip strength and metabolic syndrome in Korean postmenopausal women by time since menopause.

Menopause (New York, N.Y.)
2025

The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis.

Diabetology &amp; metabolic syndrome
2026

Laser and radiofrequency for treating genitourinary syndrome of menopause in breast cancer survivors: A systematic review of randomized controlled trial.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
2025

A case of congenital long QT syndrome and medically induced menopause.

Post reproductive health
2025

HRT-induced primary headache associated with sexual activity: A case report.

Post reproductive health
2025

Involuntary Urine Loss in Menopause-A Narrative Review.

Journal of clinical medicine
2025

Ceramide as a Biomarker for HFpEF in Women: Menopause, Aging, and Pregnancy.

International journal of molecular sciences
2025

More than just "vaginal dryness": sexual dysfunction correlates with genitourinary anatomy changes in female cancer survivors.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
2025

Women's knowledge, attitudes, and practices regarding perimenopausal syndrome in China.

BMC public health
2026

Management of sexual dysfunction in menopause: an update on evidence-based strategies.

Expert review of endocrinology &amp; metabolism
2025

TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer.

Scientific reports
2025

Effect of Danlu capsules for the treatment of breast hyperplasia with mastalgia: a multicenter, double-blind, randomized controlled trial protocol.

Frontiers in medicine
2025

Association between serum uric acid levels and primary aldosteronism.

BMC nephrology
2026

Association between metabolic syndrome and risk of cardiovascular disease among postmenopausal women: A cohort study.

Diabetes, obesity &amp; metabolism
2025

Clinical, Metabolic, and Sonographic Predictors of Endometrial Carcinoma Among Women Presenting With Postmenopausal Bleeding: A Prospective Observational Study From a Tertiary Care Center in South India.

Cureus
2026

Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study.

Menopause (New York, N.Y.)
2026

Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution.

American journal of obstetrics and gynecology
2025

Healthy aging in midlife and menopausal transition in Asia: nutrient synergy with dietary supplements.

Climacteric : the journal of the International Menopause Society
2025

Effect of kisspeptin, neurokinin, and dynorphin neurons on regulation of reproduction.

Ceska gynekologie
2026

Platelet-rich plasma in the management of vulvovaginal disorders: a systematic review.

The journal of sexual medicine
2025

Efficacy of acupuncture as an adjunctive therapy for perimenopausal insomnia: A systematic review and meta-analysis of randomized controlled trials.

Clinics (Sao Paulo, Brazil)
2025

Clinical practice perspectives on adipose-derived stem cells and platelet-rich plasma for female infertility treatments.

Future science OA
2025

Unmet needs after prevention: a model for managing premature surgical menopause post-risk-reducing bilateral salpingo-oophorectomy.

Gynecologic oncology reports
2025

Estrogenic Effect of Probiotics on Anxiety and Depression: A Narrative Review.

International journal of molecular sciences
2025

Metabolic Syndrome and Breast Cancer Risk: an Age-Dependent Paradox?

Cardiovascular drugs and therapy
2025

Multimodal large language models for women's reproductive mental health.

Archives of women's mental health
2026

Chinese herbal medicine Ding Kun Dan for menopausal syndrome: A systematic review and meta-analysis of randomized controlled trials.

Integrative medicine research
2025

Effect of vaginal laser therapy for gynecologic patients on vaginal microbiota: a prospective cohort study.

Lasers in medical science
2026

Pelvic Puzzles: Imaging Non-Traumatic Emergencies of the Female Pelvis: A Comprehensive Review.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes
2025

Genitourinary syndrome of menopause in Chinese-speaking sex workers attending an urban Australian sexual health clinic: a quality improvement project.

Sexual health
2026

Hormonal risk factors and androgen and glucocorticoid dysregulation in Sjogren's disease and non-Sjogren's sicca.

Rheumatology (Oxford, England)
2026

Geriatric syndromes in women living with HIV.

Current opinion in HIV and AIDS
2025

Osteo-sarcopenic obesity in midlife and older women: a current worldwide public health challenge.

Climacteric : the journal of the International Menopause Society
2026

Reproductive Fitness and the Links to Chronic Disease and Systemic Aging.

Physiology (Bethesda, Md.)

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de polineuropatia-perturbação do desenvolvimento intelectual-acromicria-menopausa precoce.

É de uma associação que acompanha esta doença? Fale com a gente →

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma síndrome malformativa rara que combina doença nos nervos periféricos (polineuropatia), deficiência intelectual e falência ovariana prematura. Também acarreta membros curtos, dedos encurtados e baixa estatura, tendo início registrado na fase adulta.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 5 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. Design and in vitro/in vivo evaluation of a compound estradiol-progesterone patch for the treatment of menopausal syndrome.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2026PMID 41856340
  2. ORPHA:2928
    Orphanet
  3. GARD:4424
    GARD (NIH)
  4. Q47461990
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Síndrome de polineuropatia-perturbação do desenvolvimento intelectual-acromicria-menopausa precoce. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/sindrome-de-polineuropatia-perturbacao-do-desenvolvimento-intelectual-acromicria-menopausa-precoce

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de polineuropatia-perturbação do desenvolvimento intelectual-acromicria-menopausa precoce

ORPHA:2928 · MONDO:0017379
🇧🇷 Brasil SUS
SIGTAP
5 procedimentos
Geral
Prevalência
<1 / 1 000 000
Casos
3 casos conhecidos
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
Início
Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4749397
Repurposing
14 candidatos
bazedoxifene — selective estrogen receptor modulator (SERM)
chlorotrianisene — estrogenic hormone
dehydroepiandrosterone — protein synthesis stimulant
+11 outros
Wikidata

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Rara